Companion diagnostics : from biomarker identification to market entry / issue ed. Claudio Carini
| Medienart: |
Buch |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
Hoboken, NJ: publ. on behalf of the New York Academy of Sciences by Wiley Subscription Services ; 2015 |
| Reihe: |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Carini, Claudio [Sonstige Person] |
|---|
| Nlm: |
W1 WB 141 |
|---|---|
| Themen: |
Biochemical markers |
| Anmerkungen: |
Includes bibliographical references |
|---|
| Umfang: |
VI, 89 S. ; Ill., graph. Darst. ; 26 cm |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
832634220 |
|---|
| LEADER | 01000cam a2200265 4500 | ||
|---|---|---|---|
| 001 | 832634220 | ||
| 003 | DE-627 | ||
| 005 | 20230426161752.0 | ||
| 007 | tu | ||
| 008 | 150804s2015 xxu||||| 00| ||eng c | ||
| 035 | |a (DE-627)832634220 | ||
| 035 | |a (DE-599)GBV832634220 | ||
| 035 | |a (OCoLC)919336415 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 044 | |c XD-US | ||
| 050 | 0 | |a R853.B54 | |
| 060 | 0 | |a W1 | |
| 060 | 0 | |a WB 141 | |
| 082 | 0 | |a 610.28 |q LOC |2 23 | |
| 245 | 1 | 0 | |a Companion diagnostics |b from biomarker identification to market entry |c issue ed. Claudio Carini |
| 264 | 1 | |a Hoboken, NJ |b publ. on behalf of the New York Academy of Sciences by Wiley Subscription Services |c 2015 | |
| 300 | |a VI, 89 S. |b Ill., graph. Darst. |c 26 cm | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 490 | 1 | |a Annals of the New York Academy of Sciences |v 1346 | |
| 500 | |a Includes bibliographical references | ||
| 650 | 0 | |a Biochemical markers | |
| 650 | 2 | |a Biomarkers | |
| 650 | 2 | |a Diagnostic Techniques and Procedures | |
| 650 | 2 | |a Patient-Specific Modeling | |
| 650 | 2 | |a Precision Medicine | |
| 700 | 1 | |a Carini, Claudio |4 oth | |
| 710 | 2 | |a New York Academy of Sciences |0 (DE-588)36318-2 |0 (DE-627)100835600 |0 (DE-576)190345675 |4 oth | |
| 810 | 2 | |a New York Academy of Sciences |t Annals of the New York Academy of Sciences |v 1346 |9 1346 |w (DE-627)129514802 |w (DE-576)01492420X |w (DE-600)211003-9 |x 0077-8923 |7 ns | |
| 912 | |a GBV_ILN_179 | ||
| 912 | |a ISIL_DE-B4 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a BO | ||
| 953 | |2 045F |a 610.28 | ||
| 980 | |2 179 |1 01 |x 8306 |b 1561025976 |c 00 |f B4 |d Z 3927 - 1346 |e u |j --%%-- |y z |z 04-08-15 | ||
| 982 | |2 179 |1 00 |x DE-B4 |8 00 |a Untersuchung <Medizin> | ||
| 982 | |2 179 |1 00 |x DE-B4 |8 01 |a Biomarker | ||
| 982 | |2 179 |1 00 |x DE-B4 |8 02 |a Arzneimittelentwicklung | ||
| 984 | |2 179 |1 01 |x 8306 |a B4$000497606 | ||
| 998 | |2 179 |1 01 |x 8306 |0 0815 | ||